Larry A Couture

Title: Larry A Couture: Innovator in Exosome Research

Introduction

Larry A Couture is a prominent inventor based in Claremont, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of exosome research. With a total of 2 patents, Couture's work focuses on innovative methods and compositions that have the potential to advance medical science.

Latest Patents

Couture's latest patents include groundbreaking inventions. The first patent, titled "SDC-2 exosome compositions and methods of isolation and use," discloses compositions comprising isolated exosomes. These exosomes are characterized by the presence of SDC2, with at least 20% of the exosomes comprising this marker. The patent also outlines methods for isolation and various applications of these exosomes. The second patent, "Methods of isolation and use of CD39 stromal stem cells," details techniques for isolating SDC2+ stromal stem cells through the expression of the surface marker CD39. This patent further describes the stromal stem cells that can be isolated using these methods.

Career Highlights

Larry A Couture is associated with Orbsen Therapeutics Limited, where he applies his expertise in exosome research. His work at the company has positioned him as a key player in the development of innovative therapeutic solutions. Couture's contributions have been instrumental in advancing the understanding of exosomes and their potential applications in medicine.

Collaborations

Couture has collaborated with notable professionals in his field, including Stephen Joseph Elliman and Jack Kavanaugh. These collaborations have fostered a productive environment for research and innovation, leading to significant advancements in their shared areas of expertise.

Conclusion

Larry A Couture is a distinguished inventor whose work in exosome research is paving the way for new medical advancements. His patents reflect a commitment to innovation and a deep understanding of biotechnology. Through his career at Orbsen Therapeutics Limited and collaborations with esteemed colleagues, Couture continues to make impactful contributions to the scientific community.